Health Care Supplies

20/20 Biolabs

20/20 Biolabs launches ONETEST based on IBM's AI

20/20 Biolabs released FY2025 Q3 earnings on December 12 (EST), actual revenue USD 417.98K, actual EPS USD -0.1683

20/20 Biolabs released FY2024 9 Months earnings on December 12 (EST), actual revenue USD 1.216 M, actual EPS USD -0.8991

20/20 Biolabs released FY2024 Q3 earnings on December 12 (EST), actual revenue USD 361.01K, actual EPS USD -0.3906

20/20 Biolabs released FY2025 9 Months earnings on December 12 (EST), actual revenue USD 1.507 M, actual EPS USD -0.5012

AIDX.US released FY2024 Q1 earnings on September 22, 2025 (BJT) with actual revenue of USD 427.63K and EPS of USD -0.2542

AIDX.US released FY2024 Q2 earnings on September 22, 2025 (BJT), actual revenue USD 427.63K, actual EPS USD -0.2542

20/20 Biolabs released FY2025 Q1 earnings on September 22 (EST), actual revenue USD 544.44K, actual EPS USD -0.1664

20/20 Biolabs released FY2024 Semi-Annual earnings on September 22, 2025 (EST), with actual revenue of USD 855.25 K and EPS of USD -0.5084

20/20 Biolabs released FY2025 Semi-Annual Earnings on September 22 (EST), actual revenue USD 1.089 M, actual EPS USD -0.3328

20/20 Biolabs released FY2025 Q2 earnings on September 22 (EST), actual revenue USD 544.44K, actual EPS USD -0.1664

20/20 Biolabs released FY2024 earnings on April 30 (EST), actual revenue USD 1.752 M, actual EPS USD -1.0679

20/20 Biolabs released FY2023 Q4 earnings on April 30 (EST), actual revenue USD 334.49K, actual EPS USD -0.2807

20/20 Biolabs released FY2023 Annual Earnings on April 30, 2025 (EST), with actual revenue of USD 1.424 M and EPS of USD -1.3402

Artelo Biosciences

System1

Iczoom

Next Tech

DNA X

Globavend

Agape ATP

Argan

Turbo Energy SA

IB ACQUISITION CORP. COM USD0.0001(S/R 28/09/26)

依视路(ADR)

HOYA Corporation

Medline

爱齐科技

Merit医疗系统

UFP 科技

Acme联合

Xtant医疗控股

STANDARD DENTAL LABS INC

爱尔康

Style Score

Growth Score

Revenue YoY

Net Profit YoY

Value Score

P/B Ratio

Dividend Ratio

Size Score

Market Cap Score

Market Cap

Revenue Score

Revenue

Multi Score

Profit Score

Profit Margin

Gross Margin

Total Assets YoY

Net Assets YoY

Cash Score

Cash Flow Margin

OCF YoY

Operating Score

Turnover

Debt Score

Gearing Ratio

Please note that a "Suspected value trap" is a stock that appears The stock looks financially sound and severely undervalued, but behind the low valuation is a long-term decline in business capacity or a serious financial crisis, or even the risk of bankruptcy in the short term.

Suspected value trap

20/20 Biolabs(AIDX.US)

20/20 Biolabs Stock Performance Chart